Anti-tumor agent containing anti-tumor platinum complex, and anti-tumor effect enhancer
In order to provide a novel cancer treatment method using a FTD⋅TPI combination drug that exhibits markedly excellent anti-tumor effects with fewer side effects, the present invention provides an anti-tumor agent characterized in that the FTD⋅TPI combination drug and an anti-tumor platinum complex are administered in combination..
Medienart: |
Patent |
---|
Erscheinungsjahr: |
2018 |
---|---|
Erschienen: |
2018 |
Enthalten in: |
Europäisches Patentamt - (2018) vom: 09. Okt. Zur Gesamtaufnahme - year:2018 |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
OKABE HIROYUKI [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
Themen: |
Sonstige Themen: |
---|
Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2018-10-09, Last update posted on www.tib.eu: 2023-10-11, Last updated: 2023-10-20 |
---|
Patentnummer: |
US10092589 |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
EPA004365151 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | EPA004365151 | ||
003 | DE-627 | ||
005 | 20231020095647.0 | ||
007 | cr uuu---uuuuu | ||
008 | 210529s2018 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)EPA004365151 | ||
035 | |a (EPA)US10092589 | ||
035 | |a (EPA)54240714 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 0 | |a OKABE HIROYUKI |e verfasserin |4 aut | |
245 | 1 | 0 | |a Anti-tumor agent containing anti-tumor platinum complex, and anti-tumor effect enhancer |
264 | 1 | |c 2018 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Source: www.epo.org (no modifications made), First posted: 2018-10-09, Last update posted on www.tib.eu: 2023-10-11, Last updated: 2023-10-20 | ||
520 | |a In order to provide a novel cancer treatment method using a FTD⋅TPI combination drug that exhibits markedly excellent anti-tumor effects with fewer side effects, the present invention provides an anti-tumor agent characterized in that the FTD⋅TPI combination drug and an anti-tumor platinum complex are administered in combination. | ||
650 | 4 | |a che | |
650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
650 | 4 | |a 615 | |
773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2018) vom: 09. Okt. |
773 | 1 | 8 | |g year:2018 |g day:09 |g month:10 |
856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/54240714/publication/US10092589A1?q=US10092589 |z kostenfrei |3 Volltext |
912 | |a GBV_EPA | ||
936 | u | w | |j 2018 |b 09 |c 10 |
951 | |a AR | ||
952 | |j 2018 |b 09 |c 10 |